Page 144 - Linical Workflow Optimization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical workflow optimization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Workflow Optimization Today - Breaking & Trending Today

Citeline Launches TrialScope Intelligence, Meeting the Growing Complexities of Clinical Trial Disclosure

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that ....

David Laky , Trialscope Intelligence , Scope Intelligence , Trialscope Disclose , Regulatory General Manager ,

Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results

LONDON and SALT LAKE CITY, March 30, 2023 Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive. | March 30, 2023 ....

United States , City Of , United Kingdom , Salt Lake City , New York , Sankt Peterburg , Peter Denardo , Gary Clarence Shalin Bhamra , James Mccullough , Paul Mcmanus Alice Woodings , Renalytix Ai Inc , Exchange Commission On , Investec Bank , Joslin Diabetes Center Inc , American Society Of Nephrology Kidney Week , Company Kidneyintel , European Union , American Association Of Nurse Practitioners Annual Meeting , World Obesity Federation , Pnational Kidney Foundation Spring Clinical Meeting , Community Health , Master Care Coordination Services Agreement , Veterans Administration , Services Revenue , Drug Administration , Company On ,

FDA Provides Positive Feedback to Vistagen Regarding Use of the Liebowitz Social Anxiety Scale (LSAS) as an Endpoint in Phase 3 Development of Fasedienol (PH94B) for Treatment of Social Anxiety Disorder

Vistagen plans to use the LSAS as the primary efficacy endpoint for a Phase 3 clinical study designed to evaluate fasedienol as a treatment for the overall control of symptoms of social anxiety. | March 30, 2023 ....

New York , United States , Columbia University , New York State Psychiatric Institute , Shawn Singh , Michaelr Liebowitz , Research Network , Drug Administration , York State Psychiatric Institute , Company Phase , Additional Fasedienol Program Updates , Liebowitz Social Anxiety Scale , New Drug Application , Anxiety Disorders Clinic , Managing Director , Medical Research Network , New York City , Principal Investigator , Chief Executive Officer , Adjustment Disorder , Hamilton Anxiety Scale , Vistagen Therapeutics , Nc Stock Exchange , Press Release , Ocial Vtgn Us92840h2022 ,

2023/03/29: 2022 full year results and update on clinical activities under development.

PRESS RELEASE

2022 full year results

and update on clinical activities under development.

. | March 30, 2023 ....

Serbia General , United States , Azoth Market Research , European Association Of Cardio , Management Committee , Research Tax Credit , Thoracic Surgery Congress , Market Research , French Medtech , Allied Market Research , Azoth Market , Affluent Medical , Cardio Thoracic Surgery Congress , Kreos Capital , Head Leader , Truffle Capital , Affluent Medical Stock Exchange , Press Release , Nder Afme Fr0013333077 ,

Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty

First clinical use of Stryker’s Tornier Pyrocarbon Humeral Head completed at Denver Surgery Center in Colorado
. | March 30, 2023 ....

Rose Medical Center , United States , Stryker Tornier Pyrocarbon , Tim Lanier , Armodiosm Hatzidakis , Denver Surgery Center , Stryker Corporation , Western Orthopaedics , Tornier Pyrocarbon Humeral , Investigational Device Exemption , Tornier Pyrocarbon Humeral Head , Business Wire , Upper Extremities , Pyrocarbon Humeral Head , Stryker Corporation Stock Exchange , Press Release , N Syk Us8636671013 ,